Last reviewed · How we verify

Novalgin

University Hospital, Basel, Switzerland · FDA-approved active Small molecule

At a glance

Generic nameNovalgin
SponsorUniversity Hospital, Basel, Switzerland
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results